Persistence and Evolution of SARS-CoV-2 in an Immunocompromised HostBina Choi, Jonathan Z. Li, Manish C. Choudhary et al.|New England Journal of Medicine|2020Cited by 1.4k
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsDan H. Barouch, Jaap Goudsmit, Sandra V. Kik et al.|Vaccine|2011Cited by 308
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C InfectionKshitij Wagh, Michael S. Seaman|PLoS Pathogens|2016Cited by 200
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trialsKayvon Modjarrad, Nelson L. Michael, Leyi Lin et al.|The Lancet|2017Cited by 196
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in MonkeysNorman L. Letvin, Gary J. Nabel, Miguel Lacerda et al.|Science Translational Medicine|2011Cited by 183